Sign inJoin waitlistJoin the waitlist

Joaquina Baranda

Professor, Medical Oncology · University of Kansas School of Medicine

Credentials: · · ·

History

University of Kansas School of Medicine
Present

Medical Oncology
1988–1990
Internal Medicine
1985–1988
University of Santo Tomas Faculty of Medicine and Surgery
1981–1985

Research

ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil…
Journal of Clinical Oncology · 1998 · 447 citations
Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly…
Journal of Clinical Oncology · 1997 · 434 citations
Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival
Journal of Clinical Oncology · 1996 · 350 citations

Anup Kasi
15 papers
Weijing Sun
15 papers
Raed Al Rajabi
14 papers
AS
Anwaar Saeed
11 papers
Stephen Williamson
9 papers
CL
Cynthia Leichman
7 papers
Heinz-Josef Lenz
7 papers
LL
Lawrence Leichman
7 papers
RP
Robin Park
5 papers · 5 as a resident
HS
Howard Silberman
4 papers
Mohammed Al-Jumayli
4 papers · 3 as a fellow
Rashna Madan
4 papers

Grants

Increasing Access and Participation to Early Phase Clinical Trials
National Cancer Institute · R50
Contact PI · $478.7K · University of Kansas Medical Center
2024–2029
The University of Kansas Cancer Center
National Cancer Institute · P30
Project lead · $180.2K · University of Kansas Medical Center
2012–2022

Clinical trials

A Window of Opportunity Trial of Intratumoral Injection of Copaxone® in Patients With Percutaneously Accessible Tumors
Principal investigator · Unknown · Phase 1
University of Kansas Medical Center
2019–2024
A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type Malignancies
Principal investigator · Active not recruiting · Phase 1
Joaquina Baranda
2018–2026
A Trial of Irinotecan and BKM120 in Previously Treated Advanced Colorectal Cancer
Principal investigator · Completed · Phase 1
University of Kansas Medical Center
2011–2015
Erlotinib in Treating Patients With Barrett Esophagus
Principal investigator · Unknown · Phase 1
Kansas City Veteran Affairs Medical Center
2007